NLRP3 and head and neck squamous cell carcinoma: MCC950, which is a potent, selective and small‐molecule inhibitor of NLRP3,134, 135 can relieve the pathological progression of various noninfective diseases, including ischemic stroke,136 AD,137 epilepsy,138 PD,139 AS140 and squamous cell carcinoma of the head and neck (SCCHN).80